Showing items 1 - 20 of 20

Nurses' recognition and response to unsafe practice by their peers: A qualitative descriptive analysis

Nurses’ perspectives of recognising and responding to unsafe practice by their peers: A national cross-sectional survey

Mixed method integrative review exploring nurses' recognition and response to unsafe practice

Part of the fabric and mostly right: an ethnography of ethics in clinical practice

Potency, hubris, and susceptibility: the disease mongering critique of pharmaceutical marketing

Prescription medicines: decision-making preferences of patients who receive different levels of public subsidy

Drug promotion in Australia: policy contestation and the tightening of regulation

The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?.

A prompt to the web: the media and health information seeking behaviour

An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?

Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability

Australia's pharmaceutical cost sharing policy: reducing waste or affordability ?

Australian pharmaceutical policy and the idea of innovation.

Australian pharmaceutical policy: price control, equity, and drug innovation in Australia

Disease mongering is now part of the global health debate

Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme

Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience

Moral hazard and prescription medicine use in Australia - the patient perspective

Moral hazard and prescription medicine use in Australia: the patient perspective

Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit